Tecovirimat (TPOXX) is the first FDA approved drug treatment of smallpox. In 1980, WHO declared that smallpox was eradicated; however, tecovirimat was developed as a counter to the possible use of smallpox as a bio-weapon. It is the first product awarded a Material Threat Medical Countermeasure priority review voucher by the FDA.
Recent Posts
- Beyond the Beach – Occupational Skin Cancer Risks in Outdoor Workers
- Tackling Antimicrobial Resistance: How to fight back against the rise in tough cases
- The ‘Forever Chemicals’ Crisis: What Healthcare Providers Need to Know About PFAS
- Top Challenges Faced by Emergency Medicine Residents and How to Overcome Them
- Dry January: Exploring the Health Benefits of Reducing Alcohol Intake